Skip to content

Clinical trials

Completed Lung Neoplasms trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Sweden Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20101
20111
20121
20131
20143
20154
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
Ariad Pharmaceuticals1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Eli Lilly and Company1
Genzyme, a Sanofi Company1
Gustave Roussy, Cancer Campus, Grand Paris1
Lund University1
Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms16
Carcinoma, Non-Small-Cell Lung8
Adenocarcinoma of Lung4
Carcinoma2
Carcinoma, Squamous Cell2
Adenocarcinoma1
Anus Neoplasms1
Carcinoma, Large Cell1
Cardiovascular Diseases1
Esophageal Neoplasms1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.